Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 5/2018

01-05-2018 | Research Article

Nutritional support and parenteral nutrition in cancer patients: an expert consensus report

Authors: J. A. Virizuela, M. Camblor-Álvarez, L. M. Luengo-Pérez, E. Grande, J. Álvarez-Hernández, M. J. Sendrós-Madroño, P. Jiménez-Fonseca, M. Cervera-Peris, M. J. Ocón-Bretón

Published in: Clinical and Translational Oncology | Issue 5/2018

Login to get access

Abstract

Background

Malnutrition is a frequent medical problem of cancer patients that negatively impacts their quality of life.

Methods

A multidisciplinary group of experts in Medical Oncology, Pharmacy, and Nutrition convened to discuss the management of the nutritional support in cancer patients.

Results

Of the 18 questions addressed, 9 focused on nutritional support, 5 were related to parenteral nutrition (PN) and 4 about home PN (HPN). The panel of experts recommends using nutritional screening routinely, at diagnosis and throughout the disease course, for detecting the risk of malnutrition and, if it is positive, to perform a complete nutritional assessment, to diagnose malnutrition. Currently, there are different screening tools and methods that allow us to detect nutritional risk. Based on the evidence and experience, the panel stated that PN is indicated mainly when it is not possible to use the digestive tract and/or oral feeding and/or enteral nutrition is not sufficient or possible. The nutritional needs of the cancer patients, except in those cases where individualized measures are required, should be considered similar to healthy individuals (25–30 kcal/kg/day). The panel considers that the nutritional monitoring of the cancer patient should be multidisciplinary and adapted to the characteristics of each center. Additionally, the objective of the HPN is to improve or maintain the nutritional status of a patient at home.

Conclusions

This document seeks to lay down a set of recommendations and to identify key issues that may be useful for the nutritional management of cancer patients.
Literature
1.
Gupta D, Lis CG, Granick J, Grutsch JF, Vashi PG, Lammersfeld CA. Malnutrition was associated with poor quality of life in colorectal cancer: a retrospective analysis. J Clin Epidemiol. 2006;59(7):704–9.CrossRefPubMed
2.
3.
Escortell Sánchez R, Reig García-Galbis M. Nutrición enteral en el estado nutricional del cáncer; revisión sistemática. Nutr Hosp. 2015;32(4):1408–16.PubMed
4.
Chow R, Bruera E, Chiu L, Chow S, Chiu N, Lam H, et al. Enteral and parenteral nutrition in cancer patients: a systematic review and meta-analysis. Ann Palliat Med. 2016;5(1):30–41.PubMed
5.
Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, et al. ESPEN guidelines on nutrition in cancer patients. Clin Nutr. 2017;36(1):11–48.CrossRefPubMed
6.
Segura A, Pardo J, Jara C, Zugazabeitia L, Carulla J, de Las Peñas R, et al. An epidemiological evaluation of the prevalence of malnutrition in Spanish patients with locally advanced or metastatic cancer. Clin Nutr. 2005;24(5):801–14.CrossRefPubMed
7.
Planas M, Álvarez-Hernández J, León-Sanz M, Celaya-Pérez S, Araujo K, García de Lorenzo A, PREDyCES® researchers. Prevalence of hospital malnutrition in cancer patients: a sub-analysis of the PREDyCES® study. Support Care Cancer. 2016;24(1):429–35.CrossRefPubMed
8.
Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12(5):489–95.CrossRefPubMed
9.
Mantovani G, Madeddu C. Cancer cachexia: medical management. Support Care Cancer. 2010;18(1):1–9.CrossRefPubMed
10.
Tisdale MJ. The ‘cancer cachectic factor’. Support Care Cancer. 2003;11(2):73–8.PubMed
11.
Bachmann J, Heiligensetzer M, Krakowski-Roosen H, Büchler MW, Friess H, Martignoni ME. Cachexia worsens prognosis in patients with resectable pancreatic cancer. J Gastrointest Surg. 2008;12(7):1193–201.CrossRefPubMed
12.
13.
Dewys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med. 1980;69(4):491–7.CrossRefPubMed
14.
15.
Valenzuela-Landaeta K, Rojas P, Basfi-fer K. Nutritional assessment for cancer patient. Nutr Hosp. 2012;27(2):516–23.PubMed
16.
17.
August DA. Huhmann MB; American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) Board of Directors. A.S.P.E.N. clinical guidelines: nutrition support therapy during adult anticancer treatment and in hematopoietic cell transplantation. JPEN J Parenter Enter Nutr. 2009;33(5):472–500.CrossRef
18.
19.
Bozzetti F, von Meyenfeldt MF. Nutrition support in different clinical situations: nutrition support in cancer patients. In: Lubos S, editor. Basics in clinical nutrition. 4th ed. Prague: ESPEN, GALEN; 2011. p. 573–83.
20.
Planas M, Fernández-Ortega JF, Abilés J, Spanish Society of Intensive Care Medicine and Coronary Units-Spanish Society of Parenteral and Enteral Nutrition (SEMICYUC-SENPE). Update. SEMICYUC-SENPE consensus: oncohematological patient. Med Intensiva. 2011;35(Supl 1):53–6.CrossRefPubMed
21.
Ströhle A, Zänker K, Hahn A. Nutrition in oncology: the case of micronutrients (review). Oncol Rep. 2010;24(4):815–28.CrossRefPubMed
22.
23.
Zgaga L, Theodoratou E, Farrington SM, Din FV, Ooi LY, Glodzik D, et al. Plasma vitamin D concentration influences survival outcome after a diagnosis of colorectal cancer. J Clin Oncol. 2014;32(23):2430–9.CrossRefPubMed
24.
Bolland MJ, Grey A, Gamble GD, Reid IR. The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis. Lancet Diabetes Endocrinol. 2014;4:307–20.CrossRef
25.
Autier P, Boniol M, Pizot C, Mullie P. Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol. 2014;1:76–89.CrossRef
26.
Khalid U, McGough C, Hackett C, Blake P, Harrington KJ, Khoo VS, et al. A modified inflammatory bowel disease questionnaire and the Vaizey Incontinence questionnaire are more sensitive measures of acute gastrointestinal toxicity during pelvic radiotherapy than RTOG grading. Int J Radiat Oncol Biol Phys. 2006;64(5):1432–41.CrossRefPubMed
27.
Giralt J, Regadera JP, Verges R, Romero J, de la Fuente I, Biete A, et al. Effects of probiotic Lactobacillus casei DN-114 001 in prevention of radiation-induced diarrhea: results from multicenter, randomized, placebo-controlled nutritional trial. Int J Radiat Oncol Biol Phys. 2008;71(4):1213–9.CrossRefPubMed
28.
Chitapanarux I, Chitapanarux T, Traisathit P, Kudumpee S, Tharavichitkul E, Lorvidhaya V. Randomized controlled trial of live lactobacillus acidophilus plus bifidobacterium bifidum in prophylaxis of diarrhea during radiotherapy in cervical cancer patients. Radiat Oncol. 2010;5(5):31.CrossRefPubMedPubMedCentral
29.
Palma Milla S, Lisbona Catalan A, Gómez Candela C. Nutrición parenteral en el paciente oncológico. Revisión. Nutr Clín Med. 2015;9(2):173–87.
30.
Yan X, Zhou FX, Lan T, Xu H, Yang XX, Xie CH, et al. Optimal postoperative nutrition support for patients with gastrointestinal malignancy: A systematic review and meta-analysis. Clin Nutr. 2017;36(3):710–21.CrossRefPubMed
31.
Bozzetti F, Arends J, Lundhom K, Micklewright A, Zurcher G, Muscaritoli M. ESPEN guidelines on parenteral nutrition: non-surgical oncology. Clin Nutr. 2009;28:445–54.CrossRefPubMed
32.
Derenski K, Catlin J, Allen L. Parenteral nutrition basics for the clinician caring for the adult patient. Nutr Clin Pract. 2016;31(5):578–95.CrossRefPubMed
33.
Ukleja A, Freeman KL, Gilbert K, Kochevar M, Kraft MD, Russell MK, et al. Task force on standards for nutrition support: adult hospitalized patients, and the American Society for Parenteral and Enteral Nutrition Board of Directors. Standards for nutrition support: adult hospitalized patients. Nutr Clin Pract. 2010;25(4):403–14.CrossRefPubMed
34.
Wanden-Berghe C, Sanz-Valero J, García de Lorenzo A, Martín-Peña G, Cervera M, Luengo LM, et al. Grupo CDC-Nut SENPE. Efectos adversos de la nutrición parenteral en pacientes oncológicos; revisión sistemática. Nutr Hosp. 2012;27(2):409–18.PubMed
35.
36.
Amano K, Morita T, Baba M, Kawasaki M, Nakajima S, Uemura M, et al. Effect of nutritional support on terminally ill patients with cancer in a palliative care unit. Am J Hosp Palliat Care. 2013;30:730–3.CrossRefPubMed
37.
Lundholm K, Daneryd P, Bosaeus I, Korner U, Lindholm E. Palliative nutritional intervention in addition to cyclooxygenase and erythropoietin treatment for patients with malignant disease: effects on survival, metabolism, and founction. Cancer. 2004;100:1967–77.CrossRefPubMed
38.
Bozzetti F, Cozzaglio L, Biganzoli E, Chiavenna G, De Cicco M, Donati D, et al. Quality of life and length of survival in advanced cancer patients on home parenteral nutrition. Clin Nutr. 2002;21:281–8.CrossRefPubMed
39.
Prevost V, Grach M-C. Nutritional support and quality of life in cancer patients undergoing palliative care. Eur J Cancer Care. 2012;21:581–90.CrossRef
40.
Pironi L, Arends J, Bozzetti F, Cuerda C, Gillanders L, Jeppesen PB, et al. Home Artificial Nutrition and Chronic Intestinal Failure Special Interest Group of ESPEN. ESPEN guidelines on chronic intestinal failure in adults. Clin Nutr. 2016;35(2):247–307.CrossRefPubMed
41.
Pironi L, Arends J, Bozzetti F, Cuerda C, Gillanders L, Jeppesen PB, Home Artificial Nutrition and Chronic Intestinal Failure Special Interest Group of ESPEN, et al. Corrigendum to “ESPEN guidelines on chronic intestinal failure in adults”. Clin Nutr. 2017;36(2):619.CrossRefPubMed
42.
43.
44.
Staun M, Pironi L, Bozzetti F, Baxter J, Forbes A, Joly F, et al. ESPEN guidelines on parenteral nutrition: home parenteral nutrition (HPN) in adult patients. Clin Nutr. 2009;28:467–79.CrossRefPubMed
45.
Steiger E. Consensus statements regarding optimal management of home parenteral nutrition (HPN) access. JPEN. 2006;30:S94–5.CrossRef
46.
Centers for Disease Control and Prevention. Guidelines for the prevention of intravascular catheter-related infections. MMWR. 2002;51(No. RR-10):1–29.
47.
Howard L, Ashley C. Management of complications in patients receiving home parenteral nutrition. Gastroenterology. 2003;124:1651–61.CrossRefPubMed
48.
ASPEN Board of Directors and the Standars for Specialized Nutrition Support Task Force. Standars for specialized nutrition support: home care patients. NCP. 2005;20:579–90.
49.
Kovacevich DS, Marsha EO. Consideration for home nutrition support. New York: En ASPEN Nutrition Support Practice Manual; 2005. p. 371–407.
50.
51.
Alper DS, Haynes RB. EBHC pyramid 5.0 for accessing preappraised evidence and guinace. Evid Based Med. 2016;21(4):123–5.CrossRefPubMed
52.
DiCenso A, Bayley L, Haynes B. Accessing preappraised evidence: fine-tuning the 5S model into a 6S model. ACP J Club. 2009;151(3):2–3.
Metadata
Title
Nutritional support and parenteral nutrition in cancer patients: an expert consensus report
Authors
J. A. Virizuela
M. Camblor-Álvarez
L. M. Luengo-Pérez
E. Grande
J. Álvarez-Hernández
M. J. Sendrós-Madroño
P. Jiménez-Fonseca
M. Cervera-Peris
M. J. Ocón-Bretón
Publication date
01-05-2018
Publisher
Springer International Publishing
Published in
Clinical and Translational Oncology / Issue 5/2018
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-017-1757-4

Other articles of this Issue 5/2018

Clinical and Translational Oncology 5/2018 Go to the issue

Research Article

PrediCTC, liquid biopsy in precision oncology: a technology transfer experience in the Spanish health system

Research Article

Predicting the cancer burden in Catalonia between 2015 and 2025: the challenge of cancer management in the elderly

Research Article

Application of EGFR inhibitor reduces circulating tumor cells during transcatheter arterial embolization

Brief Research Article

Modified staging system for pulmonary carcinoids on the basis of lung cancer TNM system

Review Article

Prognostic and predictive role of the PI3K–AKT–mTOR pathway in neuroendocrine neoplasms

Research Article

Oncologist’s knowledge and implementation of guidelines for breakthrough cancer pain in Spain: CONOCE study
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits